这是一篇来自已证抗体库的有关人类 GP9的综述,是根据9篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合GP9 抗体。
GP9 同义词: CD42a; GPIX; platelet glycoprotein IX; glycoprotein 9

LifeSpan Biosciences
小鼠 单克隆
  • 其他; 人类; 图 2b
LifeSpan Biosciences GP9抗体(LifeSpan BioSciences, LS-C45240)被用于被用于其他在人类样品上 (图 2b). J Immunol Methods (2016) ncbi
小鼠 单克隆
  • 其他; 人类; 图 2
LifeSpan Biosciences GP9抗体(LifeSpan, LS-C45240)被用于被用于其他在人类样品上 (图 2). J Extracell Vesicles (2015) ncbi
赛默飞世尔
小鼠 单克隆(GRP-P)
  • 流式细胞仪; 人类; 图 4c
赛默飞世尔 GP9抗体(Invitrogen, GRP-P)被用于被用于流式细胞仪在人类样品上 (图 4c). Nat Genet (2015) ncbi
Emfret Analytics
大鼠 单克隆(Xia.B4)
  • 流式细胞仪; 小鼠; 图 st2
Emfret Analytics GP9抗体(Emfret, M051-1)被用于被用于流式细胞仪在小鼠样品上 (图 st2). Nat Commun (2018) ncbi
碧迪BD
小鼠 单克隆(ALMA.16)
  • 流式细胞仪; 人类; 图 s11c
碧迪BD GP9抗体(BD, 558819)被用于被用于流式细胞仪在人类样品上 (图 s11c). Nat Commun (2018) ncbi
小鼠 单克隆(Beb1)
  • 流式细胞仪; 人类; 图 4a
碧迪BD GP9抗体(Becton Dickinson, Beb-1)被用于被用于流式细胞仪在人类样品上 (图 4a). Thromb Res (2017) ncbi
小鼠 单克隆(Beb1)
  • 流式细胞仪; 人类; 1:20; 图 11
碧迪BD GP9抗体(BD Bioscience, 340537)被用于被用于流式细胞仪在人类样品上浓度为1:20 (图 11). Oncol Lett (2016) ncbi
小鼠 单克隆(ALMA.16)
  • 流式细胞仪; 人类
碧迪BD GP9抗体(BD Biosciences, ALMA.16)被用于被用于流式细胞仪在人类样品上. Vox Sang (2016) ncbi
小鼠 单克隆(ALMA.16)
  • 流式细胞仪; 人类; 图 st1
碧迪BD GP9抗体(BD, 558819)被用于被用于流式细胞仪在人类样品上 (图 st1). Exp Cell Res (2016) ncbi
文章列表
  1. Latham S, Ehmke N, Reinke P, Taft M, Eicke D, Reindl T, et al. Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia. Nat Commun. 2018;9:4250 pubmed 出版商
  2. Pircher J, Czermak T, Ehrlich A, Eberle C, Gaitzsch E, Margraf A, et al. Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation. Nat Commun. 2018;9:1523 pubmed 出版商
  3. Hally K, La Flamme A, Larsen P, Harding S. Platelet Toll-like receptor (TLR) expression and TLR-mediated platelet activation in acute myocardial infarction. Thromb Res. 2017;158:8-15 pubmed 出版商
  4. Sierra Rivera C, Franco Molina M, Mendoza Gamboa E, Zapata Benavides P, Santaolalla Tapia J, Coronado Cerda E, et al. Effect of bovine dialyzable leukocyte extract on induction of cell differentiation and death in K562 human chronic myelogenous leukemia cells. Oncol Lett. 2016;12:4449-4460 pubmed 出版商
  5. Bæk R, Søndergaard E, Varming K, Jørgensen M. The impact of various preanalytical treatments on the phenotype of small extracellular vesicles in blood analyzed by protein microarray. J Immunol Methods. 2016;438:11-20 pubmed 出版商
  6. Rijkers M, van der Meer P, Bontekoe I, Daal B, de Korte D, Leebeek F, et al. Evaluation of the role of the GPIb-IX-V receptor complex in development of the platelet storage lesion. Vox Sang. 2016;111:247-256 pubmed 出版商
  7. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  8. Saliba J, Saint Martin C, Di Stefano A, Lenglet G, Marty C, Keren B, et al. Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies. Nat Genet. 2015;47:1131-40 pubmed 出版商
  9. Jørgensen M, Bæk R, Varming K. Potentials and capabilities of the Extracellular Vesicle (EV) Array. J Extracell Vesicles. 2015;4:26048 pubmed 出版商